Kyntra Bio, Inc. (KYNB)
6.22
+0.26
(+4.36%)
USD |
NASDAQ |
Oct 09, 16:00
6.22
0.00 (0.00%)
After-Hours: 16:05
Kyntra Bio Net Income (Quarterly) : 11.97M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.97M |
| March 31, 2026 | -15.13M |
| December 31, 2025 | -14.61M |
| September 30, 2025 | -13.15M |
| June 30, 2025 | -13.68M |
| March 31, 2025 | -16.77M |
| December 31, 2024 | -8.665M |
| September 30, 2024 | -48.29M |
| June 30, 2024 | -47.10M |
| March 31, 2024 | -49.05M |
| December 31, 2023 | -62.53M |
| September 30, 2023 | -63.62M |
| June 30, 2023 | -87.68M |
| March 31, 2023 | -76.70M |
| December 31, 2022 | -66.18M |
| September 30, 2022 | -91.65M |
| June 30, 2022 | -72.62M |
| March 31, 2022 | -63.20M |
| December 31, 2021 | -134.08M |
| September 30, 2021 | 49.80M |
| June 30, 2021 | -133.99M |
| March 31, 2021 | -71.76M |
| December 31, 2020 | -58.63M |
| September 30, 2020 | 33.00M |
| June 30, 2020 | -85.31M |
| Date | Value |
|---|---|
| March 31, 2020 | -78.35M |
| December 31, 2019 | -98.12M |
| September 30, 2019 | -49.44M |
| June 30, 2019 | 116.00M |
| March 31, 2019 | -45.41M |
| December 31, 2018 | 20.95M |
| September 30, 2018 | -42.56M |
| June 30, 2018 | -23.42M |
| March 31, 2018 | -41.40M |
| December 31, 2017 | -33.89M |
| September 30, 2017 | -24.46M |
| June 30, 2017 | -31.91M |
| March 31, 2017 | -30.61M |
| December 31, 2016 | -34.00M |
| September 30, 2016 | -24.15M |
| June 30, 2016 | 24.32M |
| March 31, 2016 | -27.84M |
| December 31, 2015 | -51.37M |
| September 30, 2015 | -45.10M |
| June 30, 2015 | 57.06M |
| March 31, 2015 | -46.37M |
| December 31, 2014 | -50.56M |
| September 30, 2014 | -39.54M |
| June 30, 2014 | 46.83M |
| March 31, 2014 | -16.24M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Vericel Corp. | 2.206M |
| Nektar Therapeutics | -40.62M |
| Capricor Therapeutics, Inc. | -40.73M |
| ARS Pharmaceuticals, Inc. | -62.34M |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | -1.474M |
| Total Expenses (Quarterly) | -13.45M |
| EPS Diluted (Quarterly) | 2.958 |
| Enterprise Value | -45.19M |
| Profit Margin (Quarterly) | -812.3% |
| Earnings Yield | 519.4% |
| Normalized Earnings Yield | 537.90 |